Search - tctmd.com

Displaying 481 - 500 of 766

Sort: Relevancy | Date

News Daily News

CLEAN-TAVI: Results of Cerebral Embolic Protection in TAVR Now in Print

Yael L. Maxwell

August 15, 2016

News Daily News

New-Onset A-Fib, Chronic Kidney Disease Are Risk Factors For Stroke After TAVR, Meta-Analysis Shows

Yael L. Maxwell

August 10, 2016

News Daily News

Next-Generation CoreValve Device Receives CE Mark for Use in Intermediate-Risk Patients

Todd Neale

August 01, 2016

News Industry News

Edwards Receives Approval For SAPIEN 3 Heart Valve In Canada

July 28, 2016

News Daily News

TCTMD’s Top 10 Most Popular Stories for July 2016

Shelley Wood

July 28, 2016

News Daily News

TAVR 后上消化道出血率高引发对抗血栓剂和 TEE 的质疑

Yael L. Maxwell

July 22, 2016

News Daily News

Los Altos Índices de Hemorragias Gastrointestinales Superiores Post-TAVR Plantean Dudas para los Antitrombóticos y ETE

Yael L. Maxwell

July 22, 2016

News Daily News

High Rates of Upper GI Bleeding After TAVR Pose Questions for Antithrombotics and TEE

Yael L. Maxwell

July 22, 2016

News Daily News

Sapien 3: Results for High-Risk, Inoperable TAVR Patients Now in Print

Yael L. Maxwell

July 12, 2016

News Opinion Conversations in Cardiology

Conversations in Cardiology: In the United States, Should TAVR Be Offered to a Low-Risk Patient?

July 11, 2016

News Daily News

TCTMD’s Top 10 Most Popular Stories for June 2016

Shelley Wood

July 01, 2016

News Features

Clots Found in the Left Atrial Appendage: A Big Deal for TAVR?

Todd Neale

June 27, 2016

News Daily News

Persistent Low-Flow Aortic Stenosis After TAVR Linked With Higher 1-Year Mortality

Michael O'Riordan

June 23, 2016

News Conference News TVT 2016

Not All Valves With Leaflet Thickening Develop Mobility Problems, Repeat 4D CT Shows in SAVORY

Michael O'Riordan

June 18, 2016

Presentation TVT 2016

Strokes After TAVR: Etiologies, Declining Frequency, and Current and Future Therapies

Presenter: Samir R. Kapadia

June 17, 2016

Presentation TVT 2016

TVT 1039: Transcatheter Aortic Valve Replacement With Evolut-R CoreValve to Simultaneously Treat Severe Calcific Aortic Stenosis and a Large Aortic Root Pseudo-aneurysm in a High-risk Patient

Presenter: Nirat Beohar

June 17, 2016

News Conference News TVT 2016

What TAVR Needs Next . . . and What It’s Getting

Shelley Wood

June 17, 2016

News Conference News TVT 2016

To Intervene or Not to Intervene When the TAVR Patient Has CAD: New Insights

Shelley Wood

June 17, 2016

News Conference News TVT 2016

Minimalist Transfemoral TAVR Reduces Costs Without Adversely Affecting Clinical Outcomes

Michael O'Riordan

June 16, 2016

News Daily News

High Mortality Following Infective Endocarditis After TAVR Warrants Better Prevention, Treatment

Yael L. Maxwell

June 15, 2016

Advertisement

CLEAN-TAVI: Results of Cerebral Embolic Protection in TAVR Now in Print

New-Onset A-Fib, Chronic Kidney Disease Are Risk Factors For Stroke After TAVR, Meta-Analysis Shows

Next-Generation CoreValve Device Receives CE Mark for Use in Intermediate-Risk Patients

Edwards Receives Approval For SAPIEN 3 Heart Valve In Canada

TCTMD’s Top 10 Most Popular Stories for July 2016

TAVR 后上消化道出血率高引发对抗血栓剂和 TEE 的质疑

Los Altos Índices de Hemorragias Gastrointestinales Superiores Post-TAVR Plantean Dudas para los Antitrombóticos y ETE

High Rates of Upper GI Bleeding After TAVR Pose Questions for Antithrombotics and TEE

Sapien 3: Results for High-Risk, Inoperable TAVR Patients Now in Print

Conversations in Cardiology: In the United States, Should TAVR Be Offered to a Low-Risk Patient?

TCTMD’s Top 10 Most Popular Stories for June 2016

Clots Found in the Left Atrial Appendage: A Big Deal for TAVR?

Persistent Low-Flow Aortic Stenosis After TAVR Linked With Higher 1-Year Mortality

Not All Valves With Leaflet Thickening Develop Mobility Problems, Repeat 4D CT Shows in SAVORY

Strokes After TAVR: Etiologies, Declining Frequency, and Current and Future Therapies

TVT 1039: Transcatheter Aortic Valve Replacement With Evolut-R CoreValve to Simultaneously Treat Severe Calcific Aortic Stenosis and a Large Aortic Root Pseudo-aneurysm in a High-risk Patient

What TAVR Needs Next . . . and What It’s Getting

To Intervene or Not to Intervene When the TAVR Patient Has CAD: New Insights

Minimalist Transfemoral TAVR Reduces Costs Without Adversely Affecting Clinical Outcomes

High Mortality Following Infective Endocarditis After TAVR Warrants Better Prevention, Treatment

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content